Torsemide

CHEMBL1148 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

348.4 g/mol

LogP

2.7

Phase

4

This loop diuretic medication helps the kidneys remove excess fluid and salt from the body, and is used to treat fluid retention (edema) caused by heart failure, kidney disease, or liver cirrhosis, as well as high blood pressure. It acts on the kidney's loop of Henle to block sodium reabsorption, producing a strong diuretic effect. Potassium levels should be monitored as the medication can cause potassium loss.

분자량

348.4000 g/mol

LogP

2.70

TPSA

109.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Cardiovascular Disease Chronic Kidney Disease Hypertension Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1

InChI

InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)

Molecular Formula

C16H20N4O3S

HBD / HBA

3 / 5

회전 가능 결합

5

무거운 원자

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This loop diuretic medication helps the kidneys remove excess fluid and salt from the body, and is used to treat fluid retention (edema) caused by heart failure, kidney disease, or liver cirrhosis, as well as high blood pressure. It acts on the kidney's loop of Henle to block sodium reabsorption, producing a strong diuretic effect. Potassium levels should be monitored as the medication can cause potassium loss.

Yes, Torsemide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1148. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 41781. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Torsemide PillFYI에서

구조

핵심 데이터

분자식: C16H20N4O3S
동의어: 3

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.